Direxion Daily S&P Biotec... (LABU)
Direxion Daily S&P Biotech Bull 3X Shares Max Pain By Strike
LABU trades at $69.27, 4.2% above the near-term max pain of $66.5 expiring Sep 5, 2025 (4 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($60-$215), signaling increased put positioning or downside protection. Key magnetic zone at 65 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Direxion Daily S&P Biotech Bull 3X Shares Max Pain By Expiry
Max pain for LABU shows a downward trend from 215 to 60, indicating bearish sentiment or hedging activity. The 184% spread signals divergent expectations across timeframes. Most levels below 69.27 may cap rallies. Strong magnetic level at 65 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 5, 2025 | 66.5 | -2.77 (-4.00%) |
| Sep 12, 2025 | 63 | -6.27 (-9.05%) |
| Sep 19, 2025 | 60 | -9.27 (-13.38%) |
| Sep 26, 2025 | 65 | -4.27 (-6.16%) |
| Oct 3, 2025 | 67 | -2.27 (-3.28%) |
| Oct 10, 2025 | 64.5 | -4.77 (-6.89%) |
| Oct 17, 2025 | 68 | -1.27 (-1.83%) |
| Dec 19, 2025 | 60 | -9.27 (-13.38%) |
| Jan 16, 2026 | 135 | 65.73 (94.89%) |
| Mar 20, 2026 | 65 | -4.27 (-6.16%) |
| Jan 15, 2027 | 215 | 145.73 (210.38%) |